InhaleRx Limited (AU:IRX) has released an update.
InhaleRx Limited experienced a net decrease in cash from operating activities, recording outflows of $439,000 for the quarter ended 31 March 2024. However, the company’s financial position was bolstered by proceeds from issuing convertible debt securities, contributing to a net increase in cash and cash equivalents of $714,000 for the period. This indicates a strategic maneuver to strengthen the company’s financials amidst ongoing expenses.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.
